全文获取类型
收费全文 | 2630篇 |
免费 | 158篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 14篇 |
儿科学 | 96篇 |
妇产科学 | 47篇 |
基础医学 | 392篇 |
口腔科学 | 47篇 |
临床医学 | 210篇 |
内科学 | 755篇 |
皮肤病学 | 37篇 |
神经病学 | 260篇 |
特种医学 | 47篇 |
外科学 | 188篇 |
综合类 | 5篇 |
预防医学 | 133篇 |
眼科学 | 6篇 |
药学 | 277篇 |
中国医学 | 21篇 |
肿瘤学 | 275篇 |
出版年
2023年 | 13篇 |
2022年 | 44篇 |
2021年 | 77篇 |
2020年 | 49篇 |
2019年 | 60篇 |
2018年 | 75篇 |
2017年 | 60篇 |
2016年 | 71篇 |
2015年 | 87篇 |
2014年 | 99篇 |
2013年 | 129篇 |
2012年 | 212篇 |
2011年 | 217篇 |
2010年 | 103篇 |
2009年 | 139篇 |
2008年 | 217篇 |
2007年 | 184篇 |
2006年 | 158篇 |
2005年 | 174篇 |
2004年 | 173篇 |
2003年 | 128篇 |
2002年 | 122篇 |
2001年 | 20篇 |
2000年 | 12篇 |
1999年 | 14篇 |
1998年 | 31篇 |
1997年 | 23篇 |
1996年 | 17篇 |
1995年 | 15篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 8篇 |
1989年 | 4篇 |
1988年 | 7篇 |
1987年 | 4篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1980年 | 4篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1975年 | 2篇 |
1973年 | 2篇 |
1971年 | 1篇 |
1967年 | 3篇 |
1890年 | 2篇 |
排序方式: 共有2810条查询结果,搜索用时 328 毫秒
61.
Stefan Porubsky Giuseppina Federico Johannes Müthing Richard Jennemann Norbert Gretz Stefan Büttner Nicholas Obermüller Oliver Jung Ingeborg A Hauser Elisabeth Gröne Helmut Geiger Hermann‐Josef Gröne Christoph Betz 《The Journal of pathology》2014,234(1):120-133
The pathogenesis and therapy of Shigatoxin 2 (Stx2)‐mediated kidney failure remain controversial. Our aim was to test whether, during an infection with Stx2‐producing E. coli (STEC), Stx2 exerts direct effects on renal tubular epithelium and thereby possibly contributes to acute renal failure. Mice represent a suitable model because they, like humans, express the Stx2‐receptor Gb3 in the tubular epithelium but, in contrast to humans, not in glomerular endothelia, and are thus free of glomerular thrombotic microangiopathy (TMA). In wild‐type mice, Stx2 caused acute tubular dysfunction with consequent electrolyte disturbance, which was most likely the cause of death. Tubule‐specific depletion of Gb3 protected the mice from acute renal failure. In vitro, Stx2 induced secretion of proinflammatory cytokines and apoptosis in human tubular epithelial cells, thus implicating a direct effect of Stx2 on the tubular epithelium. To correlate these results to human disease, kidney biopsies and outcome were analysed in patients with Stx2‐associated kidney failure (n = 11, aged 22–44 years). The majority of kidney biopsies showed different stages of an ongoing TMA; however, no glomerular complement activation could be demonstrated. All biopsies, including those without TMA, showed severe acute tubular damage. Due to these findings, patients were treated with supportive therapy without complement‐inhibiting antibodies (eculizumab) or immunoadsorption. Despite the severity of the initial disease [creatinine 6.34 (1.31–17.60) mg/dl, lactate dehydrogenase 1944 (753–2792) U/l, platelets 33 (19–124)/nl and haemoglobin 6.2 (5.2–7.8) g/dl; median (range)], all patients were discharged after 33 (range 19–43) days with no neurological symptoms and no dialysis requirement [creatinine 1.39 (range 0.84–2.86) mg/dl]. The creatinine decreased further to 0.90 (range 0.66–1.27) mg/dl after 24 months. Based on these data, one may surmise that acute tubular damage represents a separate pathophysiological mechanism, importantly contributing to Stx2‐mediated acute kidney failure. Specifically in young adults, an excellent outcome can be achieved by supportive therapy only. © 2014 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland. 相似文献
62.
63.
64.
Novo G Rizzo M La Carruba S Caruso M Amoroso GR Balistreri CR Coppola G Evola G Caruso C Assennato P Novo S Mancuso D 《Angiology》2012,63(2):127-130
We assessed whether macrophage colony-stimulating factor (M-CSF) levels are associated with left ventricular systolic dysfunction (LVSD) in patients with acute myocardial infarction (AMI). We studied 56 patients with AMI (mean age: 67 ± 12 years) and identified those with clinical (Killip class >II) or echocardiographic signs (ejection fraction ≤45%) of LVSD. We evaluated the established cardiovascular risk factors and measured several cardiovascular biomarkers, including M-CSF. Serum M-CSF concentrations (pg/mL) were significantly increased in patients with both clinical and echocardiographic signs of LVSD (460 ± 265 vs 290 ± 210, P = .0103 and 493 ± 299 vs 287 ± 174, P = .0028, respectively). We found a significant inverse association between M-CSF and ejection fraction (r = -.351, P = .0079). Logistic regression analysis revealed that, among all evaluated clinical and biochemical parameters, the stronger predictor of LVSD was M-CSF (odds ratios 2.1, 95% confidence interval 1.1-2.9, P = .0168). This is the first study reporting plasma M-CSF levels as independent determinants of low LV ejection fraction and clinical LV dysfunction in patients with AMI. 相似文献
65.
Breccia M Mazzarella L Bagnardi V Disalvatore D Loglisci G Cimino G Testi AM Avvisati G Petti MC Minotti C Latagliata R Foà R Pelicci PG Lo-Coco F 《Blood》2012,119(1):49-54
We investigated whether body mass index (BMI) correlates with distinct outcomes in newly diagnosed acute promyelocytic leukemia (APL). The study population included 144 patients with newly diagnosed and genetically confirmed APL consecutively treated at a single institution. All patients received All-trans retinoic acid and idarubicin according to the GIMEMA protocols AIDA-0493 and AIDA-2000. Outcome estimates according to the BMI were carried out together with multivariable analysis for the risk of relapse and differentiation syndrome. Fifty-four (37.5%) were under/normal weight (BMI < 25), whereas 90 (62.5%) patients were overweight/obese (BMI ≥ 25). An increased BMI was associated with older age (P < .0001) and male sex (P = .02). BMI was the most powerful predictor of differentiation syndrome in multivariable analysis (odds ratio = 7.24; 95% CI, 1.50-34; P = .014). After a median follow-up of 6 years, the estimated cumulative incidence of relapse at 5 years was 31.6% (95% CI, 22.7%-43.8%) in overweight/obese and 11.2% (95% CI, 5.3%-23.8%) in underweight/normal weight patients (P = .029). Multivariable analysis showed that BMI was an independent predictor of relapse (hazard ratio = 2.45, 95% CI, 1.00-5.99, in overweight/obese vs under/normal weight patients, P = .049). An increased BMI at diagnosis is associated with a higher risk of developing differentiation syndrome and disease relapse in APL patients treated with AIDA protocols. 相似文献
66.
67.
Maggio A Vitrano A Lucania G Capra M Cuccia L Gagliardotto F Pitrolo L Prossomariti L Filosa A Caruso V Gerardi C Campisi S Cianciulli P Rizzo M D'Ascola G Ciancio A Di Maggio R Calvaruso G Pantalone GR Rigano P 《American journal of hematology》2012,87(7):732-733
A multicenter randomized open-label long-term sequential deferiprone–deferoxamine (DFP-DFO) versus DFP alone trial (sequential DFP-DFO) performed in patients with thalassemia major (TM) was retrospectively reanalyzed to assess the variation in the left ventricular ejection fraction (LVEF) [1]. 相似文献
68.
69.
70.
Werner Lukas Pabst Thomas J. Neuhaus Samuel Nef Elena Bresin Andrea Zingg-Schenk Giuseppina Spartà 《Pediatric nephrology (Berlin, Germany)》2013,28(7):1141-1144